Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 6
2005 3
2006 7
2007 6
2008 7
2009 10
2010 7
2011 4
2012 8
2013 4
2014 4
2015 4
2016 2
2017 6
2018 14
2019 12
2020 13
2021 21
2022 21
2023 36
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma.
Guo M, Duan X, Peng X, Jin Z, Huang H, Xiao W, Zheng Q, Deng Y, Fan N, Chen K, Song X. Guo M, et al. Among authors: jin z. Nano Res. 2023;16(4):5357-5367. doi: 10.1007/s12274-022-5254-x. Epub 2023 Jan 3. Nano Res. 2023. PMID: 36618068 Free PMC article.
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors.
Sha D, Jin Z, Budczies J, Kluck K, Stenzinger A, Sinicrope FA. Sha D, et al. Among authors: jin z. Cancer Discov. 2020 Dec;10(12):1808-1825. doi: 10.1158/2159-8290.CD-20-0522. Epub 2020 Nov 2. Cancer Discov. 2020. PMID: 33139244 Free PMC article.
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials.
Yoon HH, Jin Z, Kour O, Kankeu Fonkoua LA, Shitara K, Gibson MK, Prokop LJ, Moehler M, Kang YK, Shi Q, Ajani JA. Yoon HH, et al. Among authors: jin z. JAMA Oncol. 2022 Oct 1;8(10):1456-1465. doi: 10.1001/jamaoncol.2022.3707. JAMA Oncol. 2022. PMID: 36006624 Free PMC article.
Targeted Therapies in Advanced Cholangiocarcinoma.
Storandt MH, Kurniali PC, Mahipal A, Jin Z. Storandt MH, et al. Among authors: jin z. Life (Basel). 2023 Oct 16;13(10):2066. doi: 10.3390/life13102066. Life (Basel). 2023. PMID: 37895447 Free PMC article. Review.
Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis.
Sonbol MB, Riaz IB, Naqvi SAA, Almquist DR, Mina S, Almasri J, Shah S, Almader-Douglas D, Uson Junior PLS, Mahipal A, Ma WW, Jin Z, Mody K, Starr J, Borad MJ, Ahn DH, Murad MH, Bekaii-Saab T. Sonbol MB, et al. Among authors: jin z. JAMA Oncol. 2020 Dec 1;6(12):e204930. doi: 10.1001/jamaoncol.2020.4930. Epub 2020 Dec 10. JAMA Oncol. 2020. PMID: 33090186 Free PMC article.
Antiangiogenic Therapy in Gastroesophageal Cancer.
Jin Z, Yoon HH. Jin Z, et al. Hematol Oncol Clin North Am. 2017 Jun;31(3):499-510. doi: 10.1016/j.hoc.2017.01.008. Epub 2017 Mar 22. Hematol Oncol Clin North Am. 2017. PMID: 28501090 Review.
186 results